WeHealth Digital Medicine and Nucleus Dynamics sign partnership.

By | Uncategorized



WeHealth™ Digital Medicine and Nucleus Dynamics
sign partnership in the field of diabetes

Diabetic Foot: An innovative digital solution for an improved handling of the wound


Paris, France, December 17, 2019 – WeHealthTM Digital Medicine, Servier Group’s eHealth division, and Nucleus Dynamics (a Singapore MedTech company) announce their partnership for the co-development of a digital solution for the monitoring of the evolution of diabetic wounds aimed to improve patients’ follow-up by digitizing their treatment pathway with health professionals.


The ultimate challenge: to avoid the amputation of the patient’s foot

The World Health Organization (Global Diabetes Report, 2016) estimated that 422 million people lived with diabetes in 2014. Diabetic foot is a severe chronic complication which consists of lesions in the deep tissues associated with neurological disorders and peripheral vascular disease in lower limbs. Amputation in people with diabetes is 10 to 20 times more common in comparison with those without diabetes. Digital tools can help improve wound management.


The key to the application: advanced intelligent image processing technology

WeHealth™ Digital Medicine and Nucleus Dynamics will jointly develop and commercialize an innovative digital solution intended for wound care practitioners seeking to optimize wound monitoring and treatment. This is expected to improve healthcare outcome and to facilitate collaboration between medical staff.


The solution to be commercialized is expected to be a smart mobile-based point-of-care wound management solution that uses advanced intelligent image processing technology to help overcome challenges in wound care management, enabling easy wound documentation as easy as taking a photo or a video and connecting healthcare providers and medical supplies via one sharing platform. A nurse or podiatrist would take a picture of the wound, enabling automatic measurement, and tissue type characterization. The evolution would be properly followed, through a report sent to the doctor or diabetologist.


 “Our mission is to develop innovative digital solutions to improve patients’ care. With Nucleus Dynamics’ solution, wound care management could be deeply improved with a better transmission of patients’ data through the continuum of care, from nurses to podiatrists, general practitioners and diabetologists,” says David Guez, Executive Director of Innovation and Scouting of WeHealth™ Digital Medicine.

Développer des solutions innovantes en matière de santé digitale
pour améliorer les soins prodigués aux patients


“Nucleus Dynamics is a leader in the use of artificial intelligence and connected technologies to transform how healthcare institutions diagnose and care for patients. We are very enthusiastic to partner with WeHealth Digital Medicine, an organization which believes in driving the adoption of innovative eHealth solutions to improve patient care. We look forward to our partnership and seek, through it, to bring significant progress to healthcare in wound care management,” says Marc Géniaux, CEO of Nucleus Dynamics.


WeHealth Digital Medicine is the exclusive distributor of the solution at a worldwide level. It will be first launched in the European market end of 2020.


This is the fourth WeHealth Digital Medicine’s partnership signed in the diabetes field.


About WeHealthTM Digital Medicine

Launched in November 2016, WeHealthTM Digital Medicine, the eHealth division of Servier group, aims to improve the lives of patients and healthcare professionals through digital technology. WeHealthTM Digital Medicine offers innovative digital and connected solutions as well as services making the most of collected data, to ensure better individual patient monitoring and to better prevent and predict disease progression. In an open innovative approach, WeHealthTM Digital Medicine identifies the most promising startups in eHealth, in France and internationally, to co-develop solutions. In this way, WeHealthTM Digital Medicine contributes to the creation of a partner ecosystem to facilitate and accelerate the development, industrialization, and distribution of innovations and to render them accessible to the greatest number. For more information: http://www.wehealth-digitalmedicine.com/


Press contacts:

Sonia Marques: sonia.marques@servier.com – Tel. +33 (0) 1 55 72 40 21 / +33 (0) 7 84 28 76 13

Jean-Clément Vergeau: jean-clement.vergeau@servier.com – Tel. +33 (0) 1 55 72 46 16 / +33 (0) 6 79 56 75 96

About Nucleus Dynamics

Nucleus Dynamics Pte Ltd (ND) is a Singapore MedTech company launched in 2012 with initial funding from the National Research Foundation, a department of the Singapore Prime Minister’s Office and supported by Enterprise Singapore directly and through SEEDS Capital, its investment arm.

ND has created and developed a solution with the objective of improving the health outcome and prognostic of chronic wounds by enabling the digital monitoring of wound evolution and response to treatment over time. This innovative solution is leveraging advanced technologies such as image, colour and 3D model processing and artificial intelligence. It enhances patient and healthcare staff wound care, through improved hygiene, ease-of-use, time-spent, and cross-functional collaboration.

Remote Wound Monitoring Application – National Research Foundation Singapore

By | Uncategorized

Chronic wounds take an average of six months to heal. Patients are usually discharged before the wounds heal, hence requiring the need for continuous wound monitoring. However, caregivers are often untrained and may not provide accurate information, hence Nucleus Dynamics Ptd Ltd came up with a better means of remote wound monitoring.

A mobile app was initially developed to allow medical personnel to assess wounds when they were not physically present with the patient at the time of injury or during post-treatment check-ups. Now, it has been modified to provide a software-as-a-service (SaaS) that reconstructs high-precision 3D models from videos captured by smartphones. This enables accurate colour calibration for automatic wound tissue classification.

First, this app keeps discomfort to patients to a minimum as compared to conventional methods of measurements, with the latter being more prone to human errors and subjectivity. There is a significant time reduction in wound measurement – on average, from 30 to 8 minutes. Additionally, it being a mobile app, this presents a low-cost solution for clinicians and caretakers. Finally, the use of 3D scanning and reconstruction technology can be easily replicated for use in other industries such as tourism, logistics and various industrial sectors.

The remote wound monitoring app was incubated by NTU Ventures Ptd Ltd. A $50,000 grant was given under the Interactive Digital Media Strategic Research Programme (IDM SRP), specifically the IDM Jump-start and Mentor (i.JAM) Reload Tier 1 funding initiative.

Nucleus Dynamics is a medical device start-up that works with patients, hospitals and doctors to help them manage chronic wounds more effectively, thus enabling more efficient use of hospital resources and doctors.

The National Research Foundation (NRF), set up on 1 January 2006, is a department within the Prime Minister’s Office. The NRF sets the national direction for research and development (R&D) by developing policies, plans and strategies for research, innovation and enterprise. It also funds strategic initiatives and builds up R&D capabilities by nurturing research talent. The NRF aims to transform Singapore into a vibrant R&D hub that contributes towards a knowledge-intensive, innovative and entrepreneurial economy; and make Singapore a magnet for excellence in science and innovation.

Nucleus Dynamics Was At Medica in Dusseldorf Nov 12-15 ,Booth 16G58-02

By | Uncategorized

Meet us at Medica from Nov 12 to 15, booth 16G58-02 in Singapore Pavilion!

MEDICA Dusseldorf 2018, the renowned forum for medicine, is scheduled on 12 – 15 November. A productive combination of a trade fair and congress, it has a far-reaching impact. MEDICA 2018 will highlight the innovations brought by promising start-ups – from early detection of skin cancer, through solutions for monitoring baby’s health to a smart inhaler application for asthma patients.

Farmasia and Nucleus Dynamics Sign an MOU.

By | Uncategorized

Kuala Lumpur, 3 April 2018
A Memorandum of Agreement (MoA) was inked between Farmasia Sdn Bhd with Nucleus Dynamics Pte Ltd (NDKare™) earlier today. Farmasia Sdn Bhd is a Malaysian Technology Development Corporation Business Startup Fund (BSF) recipient.
The MoA serves as a platform for a paradigm shift in the healthcare industry where a medical device company and an advanced technology company combine forces to bring value to enhance patient care, improve healthcare outcome and encourage collaboration among various disciplines within healthcare community.
Both Farmasia and Nucleus Dynamics will jointly develop and commercialise innovative digital solutions for wound care practitioners including comprehensive clinical decision support tools that will significantly simplify and standardize wound assessment and treatment. This will bring better healthcare outcome and experience to patients and improve productivity by leveraging on new technology.
NDKare™ is a smart mobile based Point-of-Care wound management solution that uses advance image processing intelligent technology to overcome challenges in the wound care industry, enables hassle-free wound documentation in seconds as easy as taking a photo and connecting patients, healthcare providers and medical supplies in one sharing platform. With NDKare™, the healthcare industry can enjoy the increase in productivity and accuracy, improve health outcome, reduce care cost, enhanced patient experience and secure sharing between disciplines. NDKare™ consists of NDKare™ App, NDKare™ Online Dashboard, NDKare™ Wound Report and NDKare™ Wound Analytics which can be used in any clinical setting that manages wounds.
Earlier during the event, Dato’ Norhalim Yunus, Chief Executive Officer MTDC mentioned that the collaboration between the two countries will include potential technology transfer and business collaboration. Farmasia, MTDC’s recipient company has expanded their foray into the global market with Dr. Wound and Atroxene Flex products.
Puan Zohrah Razak, Director of Farmasia Sdn Bhd said that the partnership is a paradigm shift for the industry and it is socially impactful as it combine their expertise in wound care treatment and technological innovation to improve healthcare outcome in resource-challenged medical industry. This is also their commitment to better serve their customers and make meaningful impact on patients’s life in Malaysia.
“Artificial Intelligence and connected medical technologies have transformed how healthcare providers diagnose and treat patients. Farmasia is a forward looking company that is committed to enhance patients experience and improve healthcare outcome at the same time, remain competitive in delivering value for money, quality products and effective clinical outcomes for its customers. We are excited about this partnership,” said Jasper Tan, Chief Executive Officer of Nucleus Dynamics.
“A study was done involving 61 patients (153 wound images) using the NDKareTM apps showed an accurate documentation of wound improvement in terms of size and other important parameters. In addition, after a period of time, we projected to save more than RM100,000 by reducing the time spent for documentations. This collaboration between an advanced wound healing treatment coupled with advanced digital imaginary is a great breakthrough. As a society, we support any advancement in the management of wounds,” said Prof. Dr. Harikrishna K. R. Nair, The President of Malaysian Society of Wound Care Professionals.

MTDC is a wholly-owned subsidiary of Khazanah Nasional Berhad and has been the key player in commercialisation and management of government funding since the 7th Malaysia Plan.
The company was set-up in 1992 to promote the adoption of technologies by local companies via commercialisation of local R&D or acquisition of foreign technologies. Since then, MTDC has been a key player in commercialisation and management of Government funds. Currently, MTDC manages six funds specifically the Commercialisation of R&D Fund (CRDF), Technology Acquisition Fund (TAF), Halal Fund, Business Start-Up Fund (BSF), Business Growth Fund (BGF) and Business Expansion Fund (BEF).
Besides fund management, MTDC also provides an integrated support services for technopreneurs which includes advisory services such as mentoring, soft-landing, branding, fund raising, international collaboration and networking. MTDC’s commercialisation ecosystem has provided funding and assistance to over 500 technology-based companies that are involved in a wide range of activities ranging from the agricultural sector to ICT.
In the 9th Malaysia Plan (9MP) and 10th Malaysia Plan (10MP) alone, companies that were recipients of MTDC’s Commercialisation of Research and Development Fund (CRDF) and Technology Acquisition Fund (TAF) generated a total of RM1.974 billion in sales and contributed towards the creation of 5,261 new jobs and a total of 465 Intellectual Property Rights were filed.

Established in May 2007, Farmasia Sdn Bhd is a major distributor and manufacturer of medical devices in Malaysia and in neighbouring countries. Their products vary in category and applications. Their main customers are made up of private and government hospitals including clinics and other healthcare providers. Malaysian Technology Development Corporation Sdn Bhd Ground Floor, Menara Yayasan Tun Razak Jalan Bukit Bintang 55100 Kuala Lumpur Malaysia Tel: +603.2172.6000 Fax: +603.2163.7570 Website: www.mtdc.com.my
FARMASIA Sdn Bhd is a GDPMD Certified company, and is registered with the Malaysian Ministry of Finance, and with Bumiputera status. Recently, Farmasia Sdn Bhd has obtained their ISO 13485:2016 accreditation and now in the final stage of obtaining Good Manufacturing Practice (GMP) certification. Recent developments has found Farmasia being awarded with the BSF Fund, which has made Farmasia a part of Malaysian Technology Development Corporation eco-system.

Nucleus Dynamics Pte Ltd (ND) is a Singapore company funded by the National Research Foundation, a department of the Singapore Prime Minister’s Office. ND is a developer of a cutting edge digital wound management solution called NDKare™. NDKare™ is a Point-of Care solution that is FDA and CE mark registered. ND’s image processing and data analytics solutions allows clinicians to intuitively capture wound photos, measure, assess and document wounds at point-of-care.

Prof. Dr. Harikrishna K.R. Nair is the president of Malaysian Society of Wound Care Professionals (MSWCP) which was formed with a theme of ‘Wound healing with passion’. MSWCP has been very supportive of the advancement of wound care in terms of trainings, workshops, and other modes of wound treatment and management. The society has been organizing various wound related events including International Wound Care conferences. This year, MSWCP will be organizing a Global Wound Conference 2018 in Kuala Lumpur.
For enquiries please contact MTDC Corporate Communications department:
Alvirah Mohd Natt – 017 212 2802; alvirah@mtdc.com.my
Sharus Shavek Sharudin – 012-358 4181; sharusshavek@mtdc.com.my